LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank83
5Y CAGR+35.0%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+35.0%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
4.5x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$543000.00+836.2%
2024$58000.00-
2023$0.00-
2022$0.00-100.0%
2021$734000.00+506.6%
2020$121000.00-
2019$0.00-